MacuLogix Launches the AdaptDx in Europe at EURETINA
MacuLogix Launches the AdaptDx in Europe at EURETINA
“Introducing the AdaptDx to the European eyecare community during EURETINA is a major milestone for our company,” said William McPhee, president and CEO of MacuLogix.
Read Press ReleaseMacuLogix Launches AMD Academy
To help you positively impact your patients’ outcomes, we’ve created the AMD Academy™. This is not only a place to view training and learn, but also a growing community. Join the AMD Academy today.
Read Press ReleaseMacuLogix Appoints Director of Professional Relations
Amanda K. Lee, OD joined MacuLogix as Director of Professional Relations. She will serve as a clinical partner to MacuLogix customers, eye care professionals and industry partners.
Read Press ReleaseAdaptDx Used in EU Study
AdaptDx® has been selected as a functional testing device in the MACUSTAR project, a 5-year study to explore AMD.
Read Press ReleaseMacuLogix Featured on Talk Radio Show
“Practical Guidelines for the Treatment of AMD” was the focus of an episode of The Power Hour.
Read Press ReleaseMacuLogix Appoints VP of Customer Experience
Robin Barnes Mattson joined MacuLogix as VP of Customer Experience. She will lead the team responsible for providing customers the tools and needed to revolutionize the management of AMD.
Read Press ReleaseMacuLogix Expands Campaign to Overcome Preventable Blindness
Damon Dierker, OD has been appointed to the company’s Clinical Advisory Panel.
Read Press ReleaseAMD Experts Unveil Treatment Guidelines Consensus Paper
Group of optometric thought-leaders issue much-needed advice in response to startling AMD statistics.
Read Press ReleaseMacuLogix Announces Optometric Advisory Board
Seven industry leaders to provide strategic input on the AdaptDx and practical guidelines for AMD
Read Press ReleaseMacuLogix Announces Communication Guide for Eye Care Professionals
The document is a step-by-step communication guide for eye care professionals treating patients with AMD.
Read Press Release